BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4152781)

  • 41. The expression of theta-like antigen by rat peripheral lymphocytes: serologic and functional studies.
    Douglas TC; Dowsett AP
    J Immunol; 1975 Jul; 115(1):283-8. PubMed ID: 1151060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular immunology and the pathogenesis of graft versus host reactions.
    Elkins WL
    Prog Allergy; 1971; 15():78-187. PubMed ID: 4151282
    [No Abstract]   [Full Text] [Related]  

  • 43. Selective retention of T cell precursors in bone marrow. Cell populations after filtration through anti-immunoglobulin columns.
    Rubin B; Trier L; Hertel-Wulff B; Rumler B
    Cell Immunol; 1975 Apr; 16(2):315-29. PubMed ID: 234799
    [No Abstract]   [Full Text] [Related]  

  • 44. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 45. Modulation of the immune response by antigen-reactive lymphocytes after cultivation with gangliosides.
    Miller HC; Esselman WJ
    J Immunol; 1975 Sep; 115(3):839-43. PubMed ID: 1097530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T cell suppression in vitro. I. Role in regulation of antibody responses.
    Feldmann M
    Eur J Immunol; 1974 Oct; 4(10):660-6. PubMed ID: 4547708
    [No Abstract]   [Full Text] [Related]  

  • 47. Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice.
    Stanbredge EJ; Boulger LR; Franks CR; Garrett JA; Reeson DE; Bishop D; Perkins FT
    Cancer Res; 1975 Aug; 35(8):2203-12. PubMed ID: 1080073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse.
    Duquesnoy RJ
    J Immunol; 1972 Jun; 108(6):1578-90. PubMed ID: 4402311
    [No Abstract]   [Full Text] [Related]  

  • 50. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
    Sykes M; Chester CH; Sundt TM; Romick ML; Hoyles KA; Sachs DH
    J Immunol; 1989 Dec; 143(11):3503-11. PubMed ID: 2584703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of anti-thymocyte serum with haematopoietic stem cells. II. Stimulation of colony formation in vitro.
    Mookerjee BK; Poulter L
    Immunology; 1974 Oct; 27(4):601-7. PubMed ID: 4140146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells.
    Harding B; MacLennan IC
    Immunology; 1972 Jul; 23(1):35-43. PubMed ID: 4558093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carrier specificity and the allogeneic effect in mice.
    Rajewsky K; Roelants GE; Askonas BA
    Eur J Immunol; 1972 Dec; 2(6):592-8. PubMed ID: 4144030
    [No Abstract]   [Full Text] [Related]  

  • 55. Antigenic correlations between brain and thymus. I. Common antigenic structures in rat and mouse brain tissue and thymocytes.
    Thiele HG; Stark R; Keeser D
    Eur J Immunol; 1972 Oct; 2(5):424-9. PubMed ID: 4538915
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization of the anti-stem cell activity of anti-mouse brain serum.
    Monette FC; Eichacker PQ; Garver RI; Byrt W; Gilio MJ
    Exp Hematol; 1978 Mar; 6(3):299-310. PubMed ID: 648593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T and B lymphocytes in New Zealand black mice. An analysis of the theta, TL and MBLA markers.
    Waksman BH; Raff MC; East J
    Clin Exp Immunol; 1972 May; 11(1):1-11. PubMed ID: 4402642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variation in T and B cell deficiency in different mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1974 Dec; 113(6):1770-9. PubMed ID: 4279262
    [No Abstract]   [Full Text] [Related]  

  • 59. Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.
    Treiber W; Lapp WS
    Transplantation; 1973 Sep; 16(3):211-6. PubMed ID: 4147031
    [No Abstract]   [Full Text] [Related]  

  • 60. Ability of anti-brain heteroantisera to distinguish thymus-derived lymphocytes in various species.
    Kongshavn PA; Gold P; Shuster J; Colquhoun B; Freedman SO
    Clin Immunol Immunopathol; 1974 Sep; 3(1):1-15. PubMed ID: 4548010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.